Managing director, Antonio Fernandez Medarde, states that this factory’s capacity for the production of active raw materials comes to over 3,000 litres in its different tanks, representing a major quantitative and qualitative increase.
In his opinion the expansion of Biomar’s API production factory comes in response to the growing demand for production exhibited by portions of the pharmaceutical, food, cosmetics and energy sectors. 95% of its capacity will be employed to serve foreign multinationals, while 5% will be for companies on the domestic market. “Despite the economic crisis, the major foreign multinationals from the U.S. and Europe have not reduced their outlays designated for research, unlike what is happening in our country,” said company vice president Arturo Ayats.
This expansion, targeting industrial production for third parties, complements the continuous production of compounds, molecules and active raw materials carried out by the Biomar Microbial Technologies research team. This new factory shall be dedicated to the production of small molecules and proteins which require bacteria, fungi and yeast fermentation processes or the cultivation of mammalian cells for the completion of preclinical and clinical studies.
Source: Biomar Microbial Technologies
© FoodBev Media Ltd 2024